Parkinson's Disease: A Prionopathy?

Int J Mol Sci. 2021 Jul 27;22(15):8022. doi: 10.3390/ijms22158022.

Abstract

The principal pathogenic event in Parkinson's disease is characterized by the conformational change of α-synuclein, which form pathological aggregates of misfolded proteins, and then accumulate in intraneuronal inclusions causing dopaminergic neuronal loss in specific brain regions. Over the last few years, a revolutionary theory has correlated Parkinson's disease and other neurological disorders with a shared mechanism, which determines α-synuclein aggregates and progresses in the host in a prion-like manner. In this review, the main characteristics shared between α-synuclein and prion protein are compared and the cofactors that influence the remodeling of native protein structures and pathogenetic mechanisms underlying neurodegeneration are discussed.

Keywords: Parkinson’s disease; gut microbiota; prion-like mechanism; protein misfolding co-factors; α-synuclein.

Publication types

  • Review

MeSH terms

  • Animals
  • Dopaminergic Neurons / metabolism
  • Dopaminergic Neurons / pathology
  • Humans
  • Parkinson Disease* / metabolism
  • Parkinson Disease* / pathology
  • Prion Diseases* / metabolism
  • Prion Diseases* / pathology
  • Protein Aggregates*
  • alpha-Synuclein / metabolism*
  • tau Proteins / metabolism*

Substances

  • MAPT protein, human
  • Protein Aggregates
  • SNCA protein, human
  • alpha-Synuclein
  • tau Proteins